These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

266 related articles for article (PubMed ID: 37265479)

  • 1. Pulmonary bacteriophage and cystic fibrosis airway mucus: friends or foes?
    Ling KM; Stick SM; Kicic A
    Front Med (Lausanne); 2023; 10():1088494. PubMed ID: 37265479
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Challenges and Promises for Planning Future Clinical Research Into Bacteriophage Therapy Against
    Rossitto M; Fiscarelli EV; Rosati P
    Front Microbiol; 2018; 9():775. PubMed ID: 29780361
    [TBL] [Abstract][Full Text] [Related]  

  • 3.
    Vaitekenas A; Tai AS; Ramsay JP; Stick SM; Kicic A
    Antibiotics (Basel); 2021 Feb; 10(2):. PubMed ID: 33540528
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bacteriophage Adherence to Mucus Mediates Preventive Protection against Pathogenic Bacteria.
    Almeida GMF; Laanto E; Ashrafi R; Sundberg LR
    mBio; 2019 Nov; 10(6):. PubMed ID: 31744913
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Subdiffusive motion of bacteriophage in mucosal surfaces increases the frequency of bacterial encounters.
    Barr JJ; Auro R; Sam-Soon N; Kassegne S; Peters G; Bonilla N; Hatay M; Mourtada S; Bailey B; Youle M; Felts B; Baljon A; Nulton J; Salamon P; Rohwer F
    Proc Natl Acad Sci U S A; 2015 Nov; 112(44):13675-80. PubMed ID: 26483471
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The potential of phage therapy in cystic fibrosis: Essential human-bacterial-phage interactions and delivery considerations for use in Pseudomonas aeruginosa-infected airways.
    Trend S; Fonceca AM; Ditcham WG; Kicic A; Cf A
    J Cyst Fibros; 2017 Nov; 16(6):663-670. PubMed ID: 28720345
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relevance of the bacteriophage adherence to mucus model for
    Almeida GMdF; Ravantti J; Grdzelishvili N; Kakabadze E; Bakuradze N; Javakhishvili E; Megremis S; Chanishvili N; Papadopoulos N; Sundberg L-R
    Microbiol Spectr; 2024 Jun; ():e0352023. PubMed ID: 38912817
    [No Abstract]   [Full Text] [Related]  

  • 8. Unplugging Mucus in Cystic Fibrosis and Chronic Obstructive Pulmonary Disease.
    Mall MA
    Ann Am Thorac Soc; 2016 Apr; 13 Suppl 2():S177-85. PubMed ID: 27115954
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhaled Bacteriophage Therapy for Multi-Drug Resistant
    Winzig F; Gandhi S; Lee A; Würstle S; Stanley GL; Capuano I; Neuringer I; Koff JL; Turner PE; Chan BK
    Yale J Biol Med; 2022 Dec; 95(4):413-427. PubMed ID: 36568830
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Temperate Bacteriophages from Chronic Pseudomonas aeruginosa Lung Infections Show Disease-Specific Changes in Host Range and Modulate Antimicrobial Susceptibility.
    Tariq MA; Everest FLC; Cowley LA; Wright R; Holt GS; Ingram H; Duignan LAM; Nelson A; Lanyon CV; Perry A; Perry JD; Bourke S; Brockhurst MA; Bridge SH; De Soyza A; Smith DL
    mSystems; 2019 Jun; 4(4):. PubMed ID: 31164451
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of a Primary Epithelial Cell Screening Tool to Investigate Phage Therapy in Cystic Fibrosis.
    Trend S; Chang BJ; O'Dea M; Stick SM; Kicic A; ; ;
    Front Pharmacol; 2018; 9():1330. PubMed ID: 30546305
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Chinese experts consensus statement: diagnosis and treatment of cystic fibrosis (2023)].
    ; ;
    Zhonghua Jie He He Hu Xi Za Zhi; 2023 Apr; 46(4):352-372. PubMed ID: 36990700
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In Vitro Newly Isolated Environmental Phage Activity against Biofilms Preformed by
    Fiscarelli EV; Rossitto M; Rosati P; Essa N; Crocetta V; Di Giulio A; Lupetti V; Di Bonaventura G; Pompilio A
    Microorganisms; 2021 Feb; 9(3):. PubMed ID: 33668889
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cystic fibrosis airway epithelial Ca2+ i signaling: the mechanism for the larger agonist-mediated Ca2+ i signals in human cystic fibrosis airway epithelia.
    Ribeiro CM; Paradiso AM; Carew MA; Shears SB; Boucher RC
    J Biol Chem; 2005 Mar; 280(11):10202-9. PubMed ID: 15647273
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CFTR delivery to 25% of surface epithelial cells restores normal rates of mucus transport to human cystic fibrosis airway epithelium.
    Zhang L; Button B; Gabriel SE; Burkett S; Yan Y; Skiadopoulos MH; Dang YL; Vogel LN; McKay T; Mengos A; Boucher RC; Collins PL; Pickles RJ
    PLoS Biol; 2009 Jul; 7(7):e1000155. PubMed ID: 19621064
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bacteriology and treatment of infections in the upper and lower airways in patients with primary ciliary dyskinesia: adressing the paranasal sinuses.
    Alanin MC
    Dan Med J; 2017 May; 64(5):. PubMed ID: 28552099
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bacteriophages φMR299-2 and φNH-4 can eliminate Pseudomonas aeruginosa in the murine lung and on cystic fibrosis lung airway cells.
    Alemayehu D; Casey PG; McAuliffe O; Guinane CM; Martin JG; Shanahan F; Coffey A; Ross RP; Hill C
    mBio; 2012; 3(2):e00029-12. PubMed ID: 22396480
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hybrid Lipid/Polymer Nanoparticles to Tackle the Cystic Fibrosis Mucus Barrier in siRNA Delivery to the Lungs: Does PEGylation Make the Difference?
    Conte G; Costabile G; Baldassi D; Rondelli V; Bassi R; Colombo D; Linardos G; Fiscarelli EV; Sorrentino R; Miro A; Quaglia F; Brocca P; d'Angelo I; Merkel OM; Ungaro F
    ACS Appl Mater Interfaces; 2022 Feb; 14(6):7565-7578. PubMed ID: 35107987
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bacteriophage adhering to mucus provide a non-host-derived immunity.
    Barr JJ; Auro R; Furlan M; Whiteson KL; Erb ML; Pogliano J; Stotland A; Wolkowicz R; Cutting AS; Doran KS; Salamon P; Youle M; Rohwer F
    Proc Natl Acad Sci U S A; 2013 Jun; 110(26):10771-6. PubMed ID: 23690590
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dysfunctional Inflammation in Cystic Fibrosis Airways: From Mechanisms to Novel Therapeutic Approaches.
    Ghigo A; Prono G; Riccardi E; De Rose V
    Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33669352
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.